Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780222 | SCV000917315 | likely benign | not specified | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000862711 | SCV001003253 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003344039 | SCV004068084 | likely benign | Cardiovascular phenotype | 2023-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000780222 | SCV001925158 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001702560 | SCV001930042 | likely benign | not provided | no assertion criteria provided | clinical testing |